Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective
Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective
复制标题
DOI：
10.1128/aac.45.12.3623-3624.2001
复制
发表时间：
2001-12-01
影响因子：
4.9
通讯作者：
Reller, LB
中科院分区：
文献类型：
--
作者：
Murdoch, DR;Reller, LB
Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resistant to gentamicin. Erythromycin and clindamycin are no longer reliable empirical alternatives to penicillin for the treatment and prevention of group B streptococcal infections.
